Total Payments
$4,781
2024 Payments
$1,044
Companies
52
Transactions
232
Medicare Patients
2,803
Medicare Billing
$335,869
Payment Breakdown by Category
Food & Beverage$4,253 (89.0%)
Research$465.00 (9.7%)
Education$45.06 (0.9%)
Gifts$18.00 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,253 | 227 | 89.0% |
| Unspecified | $465.00 | 1 | 9.7% |
| Education | $45.06 | 3 | 0.9% |
| Gift | $18.00 | 1 | 0.4% |
Payments by Type
General
$4,316
231 transactions
Research
$465.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $695.38 | 48 | $0 (2024) |
| Novo Nordisk Inc | $561.04 | 25 | $0 (2024) |
| Eli Lilly and Company | $465.00 | 1 | $0 (2023) |
| Abbott Laboratories | $407.31 | 24 | $0 (2024) |
| Dexcom, Inc. | $263.89 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $185.91 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $177.06 | 9 | $0 (2024) |
| Amgen Inc. | $166.35 | 8 | $0 (2024) |
| Medtronic MiniMed, Inc. | $123.35 | 3 | $0 (2019) |
| Insulet Corporation | $122.74 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,044 | 44 | Novo Nordisk Inc ($280.61) |
| 2023 | $1,239 | 43 | Eli Lilly and Company ($465.00) |
| 2022 | $553.39 | 31 | Lilly USA, LLC ($104.52) |
| 2021 | $246.81 | 13 | Nevro Corp. ($33.72) |
| 2020 | $123.25 | 7 | Companion Medical, Inc. ($20.82) |
| 2019 | $445.46 | 29 | Lilly USA, LLC ($139.18) |
| 2018 | $781.56 | 46 | Lilly USA, LLC ($139.14) |
| 2017 | $347.59 | 19 | Abbott Laboratories ($62.50) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/01/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: Automated insulin delivery system | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Diabetes Care | ||||||
| 09/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Obesity | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $99.37 | General |
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: Automated insulin delivery system | ||||||
| 07/25/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: Insulin Pump | ||||||
| 07/08/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Durable Pump | ||||||
| 06/22/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $45.51 | General |
| 06/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Hyperthyroidism | ||||||
| 06/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: Obesity | ||||||
| 06/05/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.19 | General |
| 06/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Diabetes Care | ||||||
| 05/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) | Eli Lilly and Company | $465.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 757 | 1,066 | $259,842 | $91,470 |
| 2022 | 8 | 774 | 1,122 | $279,233 | $98,976 |
| 2021 | 7 | 619 | 837 | $203,925 | $74,086 |
| 2020 | 9 | 653 | 954 | $229,929 | $71,337 |
Total Patients
2,803
Total Services
3,979
Medicare Billing
$335,869
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 472 | 721 | $173,040 | $63,491 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $22,940 | $7,225 | 31.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 37 | 37 | $17,131 | $6,072 | 35.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 63 | 67 | $19,631 | $5,368 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 37 | $11,914 | $5,306 | 44.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 75 | 125 | $12,500 | $3,156 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 17 | $2,686 | $851.37 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 463 | 754 | $180,960 | $67,618 | 37.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 85 | 93 | $27,249 | $7,965 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $22,570 | $6,972 | 30.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 39 | 39 | $18,057 | $6,524 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 31 | $9,982 | $4,154 | 41.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 63 | 108 | $10,800 | $2,683 | 24.8% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 17 | 17 | $6,613 | $1,912 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 19 | $3,002 | $1,147 | 38.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 396 | 578 | $138,720 | $52,122 | 37.6% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 67 | 72 | $21,096 | $6,432 | 30.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 28 | $9,016 | $4,051 | 44.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $11,840 | $3,961 | 33.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $10,649 | $3,678 | 34.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 38 | $6,004 | $2,094 | 34.9% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 47 | 66 | $6,600 | $1,748 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 389 | 628 | $150,720 | $46,849 | 31.1% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 63 | 72 | $21,096 | $6,248 | 29.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 52 | 52 | $19,240 | $5,536 | 28.8% |
About Dr. Jean Chen, M.D
Dr. Jean Chen, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1467741132.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jean Chen, M.D has received a total of $4,781 in payments from pharmaceutical and medical device companies, with $1,044 received in 2024. These payments were reported across 232 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($4,253).
As a Medicare-enrolled provider, Chen has provided services to 2,803 Medicare beneficiaries, totaling 3,979 services with total Medicare billing of $335,869. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Austin, TX
- Active Since 04/04/2011
- Last Updated 09/20/2016
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1467741132
Products in Payments
- MOUNJARO (Drug) $242.15
- FREESTYLE LIBRE 3 (Device) $204.24
- Dexcom G6 Transmitter (Medical Supply) $185.30
- FARXIGA (Drug) $162.87
- JARDIANCE (Drug) $152.48
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $138.27
- Rybelsus (Drug) $126.29
- Minimed 670G System (Device) $123.35
- Omnipod (Device) $122.74
- HUMULIN (Drug) $96.63
- iLet Bionic Pancreas (Device) $86.43
- Ozempic (Drug) $85.64
- V-GO (Device) $83.99
- LEQVIO (Drug) $81.32
- Korlym (Drug) $81.18
- MINIMED 780G (Device) $73.70
- TRULICITY (Drug) $73.19
- Kerendia (Drug) $72.19
- Saxenda (Drug) $68.66
- SYNTHROID (Drug) $67.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Austin
Dr. Thomas Blevins, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Endocrinology, Diabetes & Metabolism $1.5M
Michele Mcdermott, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $137,974
Endocrinology, Diabetes & Metabolism $137,974
Tira Chaicha-Brom, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $56,872
Endocrinology, Diabetes & Metabolism $56,872
Dr. Simona Scumpia, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $52,573
Endocrinology, Diabetes & Metabolism $52,573
Dr. Padma Horvit, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $20,822
Endocrinology, Diabetes & Metabolism $20,822
Farheen Yousuf, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,161
Endocrinology, Diabetes & Metabolism $9,161